DalsnaFinance › IPOs › Atrium Therapeutics Inc › IPO
Avidity Biosciences, Inc. completed its initial public offering on NASDAQ on June 12, 2020, pricing at $18.00 a share.
| Ticker | RNA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 12, 2020 |
| Offering price | $18.00 |
| Shares offered | 14,400,000 |
| Total raised | $259M |
Avidity Biosciences, Inc. sold 14,400,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $259.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $259 million total recorded for the deal.
Avidity Biosciences, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Avidity Biosciences, Inc.. This page is general information, not investment advice.